News From the USA 'Experimental drug slows kidney cancer'

Reuters10	Reuters10	Reuters10	Reuters10	Reuters10	Reuters10	Reuters10
Reuters10	Reuters10

One off donation
Regular donation

NICE reject Bevacizumab, sorafenib and temsirolimus >>

Press archive - 2009 >>

Press archive - 2010 >>

Press archive - 2008 >>

Press archive - 2007 >>

Press archive - 2006 >>

HEALTH MINISTER ORDERS CLINICAL AUDIT ON ACCESSING KIDNEY CANCER DRUG >>
24 December 2008

James Whale Talks To Mature Times >>
13 October 2008

Continuing the Fight >>
6 September 2008

NICE Demo >>
2 September 2008

James Whale on GMTV Talking about NICE >>
9 August 2008

Countrywide announce James Whale Fund for Kidney Cancer as Staff Charity >>
21 July 2008

Cyclists arrive at Journey's End >>
3 June 2008

James Whale Blog: May/ June 2008 >>
21 May 2008

Move to North could help cancer patient live - The Sunday Sun >>
20 May 2008

News From the USA 'Experimental drug slows kidney cancer' >>
20 May 2008

Salford PCT declined to pay for Sutent >>
20 May 2008

James Whale Blog - April 2008 >>
9 April 2008

NICE is recruiting new members to independent advisory committees on the use of health technologies. >>
3 March 2008

Comment From: James Whale >>
1 February 2008

Carol Vorderman supports UK Patient Survey >>
1 February 2008

20 May 2008

Reuters report from America that an experimental drug called RAD-001 or everolimus from Swiss drugmaker Novartis slowed the progression of kidney cancer in patients whose tumors returned after initial chemotherapy,